CLEU Diagnostics LLC – Trademark Portfolio

Entity Type: 16

CLEU Diagnostics LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include CLEU DIAGNOSTICS. The owner is based in Philadelphia, PA.

Sheridan Building, Suite 1001

125 S. 9th Street

Philadelphia, PA 19107

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CLEU Diagnostics LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CLEU Diagnostics LLC have?

CLEU Diagnostics LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 2 abandoned.

What trademark classes does CLEU Diagnostics LLC file in?

CLEU Diagnostics LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CLEU Diagnostics LLC's most well-known trademarks?

CLEU Diagnostics LLC's registered trademark portfolio includes well-known marks such as CLEU DIAGNOSTICS. These are among 1 currently registered trademark in the portfolio.

What is CLEU Diagnostics LLC's trademark registration success rate?

CLEU Diagnostics LLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.